Hyperion Defi (HYPD) Treasury Shares (2017 - 2026)

Hyperion Defi (HYPD) posted quarterly Treasury Shares of $253558.0 for Q4 2025.

Hyperion Defi (HYPD) Treasury Shares (2017 - 2026) Analysis & Trends

Hyperion Defi (HYPD) has reported Treasury Shares for 1 consecutive years, with $253558.0 the latest figure, recorded in Q4 2025.

In Q1 2026, Treasury Shares rose 494.03% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 494.03% YoY), while the FY2025 annual figure was $1.5 million, up 33428.65% from the prior year.
Treasury Shares rose to $1.5 million in Q1 2026 per HYPD's latest filing, from $82324.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.6 million in Q3 2025 and bottomed at $1322.0 in Q4 2023.
Historically, Treasury Shares has averaged $315655.4 across 5 years, with a median of $150578.0 in 2023.
Annual changes were most pronounced in 2023 — Treasury Shares tumbled 99.23% — and 2025, when it jumped 1686.55%.
Hyperion Defi's Treasury Shares stood at $172800.0 in 2022, then sank by 99.23% to $1322.0 in 2023, then jumped by 248.56% to $4608.0 in 2024, then surged by 1686.55% to $82324.0 in 2025, then jumped by 1665.04% to $1.5 million in 2026.
Business Quant data shows HYPD's Treasury Shares at $1.5 million in Q1 2026, $82324.0 in Q4 2025, and $1.6 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.29 Bn	78.30 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	65.17 Bn	59.98 Bn	1.37 Bn	-
4	Moderna	61.38 Bn	56.24 Bn	52.00 Mn	-
5	BeOne Medicines	42.18 Bn	37.09 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.99 Bn	27.68 Bn	992.69 Mn	-
7	BioNTech SE	28.45 Bn	10.05 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Hyperion Defi	47.20 Mn	37.56 Mn	357,693.00	-

Download Data